Discover and read the best of Twitter Threads about #SGLT2Inhibitors
Most recents (2)
THREAD: SGLT2 inhibitors for #diabetes
1/5 Dr. Jamie Falk @jamisonfalk presented "A Deep Dive into #SGLT2i: What Comes to the Surface for Individuals with Diabetes"
👉🏽Watch the presentation here: bit.ly/3FRCEoM 🧑🏾💻
#T2DM #medsafety #FOAMed #MedEd
1/5 Dr. Jamie Falk @jamisonfalk presented "A Deep Dive into #SGLT2i: What Comes to the Surface for Individuals with Diabetes"
👉🏽Watch the presentation here: bit.ly/3FRCEoM 🧑🏾💻
#T2DM #medsafety #FOAMed #MedEd
2/5 #AdverseEffects for #SGLT2i to be aware of: genital infections, hypovolemia, DKA, amputations
✅Check out the image ⬇️ for the risk estimates
✅Watch @JamisonFalk's presentation here: bit.ly/3FRCEoM🧑🏾💻
#T2DM #medsafety #FOAMed #MedEd #diabetes #ptsafety
✅Check out the image ⬇️ for the risk estimates
✅Watch @JamisonFalk's presentation here: bit.ly/3FRCEoM🧑🏾💻
#T2DM #medsafety #FOAMed #MedEd #diabetes #ptsafety
3/5 Evidence to date for #SGLT2i:
The first of the two new classes of medications for type II diabetes to reduce ↘️ risk of CV #AdverseEvents and mortality
✅Watch @JamisonFalk's presentation here: bit.ly/3FRCEoM🧑🏾💻
#T2DM #medsafety #FOAMed #MedEd #diabetes
The first of the two new classes of medications for type II diabetes to reduce ↘️ risk of CV #AdverseEvents and mortality
✅Watch @JamisonFalk's presentation here: bit.ly/3FRCEoM🧑🏾💻
#T2DM #medsafety #FOAMed #MedEd #diabetes
Ready for a short @thecurbsiders recap #tweetorial on #SGLT2Inhibitors Ep 204 #NephMadness Hat tip to the Shownotes @BrighamSK @PaulNWilliamz @DoctorWatto @kidney_boy @HannahRAbrams
SGLT2i Pearls:
1. SGLT2 inhibitors have significant long-term protection of GFR. However, because they cause afferent arteriolar vasoconstriction, expect to see an acute drop in GFR after initiating.
1. SGLT2 inhibitors have significant long-term protection of GFR. However, because they cause afferent arteriolar vasoconstriction, expect to see an acute drop in GFR after initiating.
2. SGLT2 inhibitors work w/ ACEi/ARBs & can still provide improvement in renal outcomes for pts w/ diabetic kidney disease on max dose ACEi/ARB.
3. Patients already on thiazide can experience significant volume loss with SGLT2i initiation. Consider reducing or stopping thiazides
3. Patients already on thiazide can experience significant volume loss with SGLT2i initiation. Consider reducing or stopping thiazides
